Best Practices

Study shows clinically significant reductions in postprandial glucose and insulin.

In Ontario, nearly 900,000 people live with chronic obstructive pulmonary disease (COPD).

The new program will offer governments and other stakeholders more information about the long-term effectiveness and safety of drugs on the market.

The preprint study, which has not been peer-reviewed, was published online on Sept. 9.

New analysis finds vast majority of Canadian clinical trials aren’t prospectively registering, reporting their results, and publishing their findings.

Adjusting for demographics and hours/weeks of work, we found that on average female physicians earn about 9% less than their male counterparts, finds health economist Boris Kralj.

Patients and their families have rallied behind the drug from Amylyx Pharma, launching an aggressive lobbying campaign and enlisting members of Congress to push the U.S. Food and Drug Administration to grant approval.